期刊文献+

血浆置换治疗重型肝炎对病毒载量的影响及临床意义

Effect of Plasma Exchange on Serum Level of HBV - DNA and Its Clinical Significance in Patients with Severe Hepatitis
下载PDF
导出
摘要 目的观察并探讨血浆置换(PE)治疗后重型肝炎患者血清中HBV-DNA载量的变化及其临床意义。方法随机选取48例乙型肝炎病毒标志物阳性的重肝患者,在内科基础治疗上加用血浆置换治疗。观察患者在PE治疗前后血清中HBV-DNA载量的变化及各项肝功能指标的变化。结果48例患者经PE治疗,血清HBV(?)DNA载量明显下降,治疗有效组比治疗无效组降低更明显,对肝功能和临床症状的改善也更明显。结论PE治疗可有效去除重型肝炎患者血清中HBV-DNA,从而减轻由其诱发的机体免疫反应,改善临床症状及肝功能,提高患者的存活率。 Objective To observe and evaluate the effect of plasma exchange(PE) on the serum level of HBV - DNA and its clinical significance in patients with severe hepatitis . Methods PE treatment on the basis of medical treatment was performed in 48 patients with severe hepatitis B, who were randomly selected from the patients with severe hepatitis B treated in our department from October 2000 to October 2003, The serum level of HBV - DNA and liver fimetion before and after PE therapy were examined. Restults The serum level of HBV - DNA was significantly decreased and the liver function were significanfly improved after PE therapy corollated to the pretreatment ( P 〈 0.01 ) in all the patients. The decrease in the level of serum HBV - DNA and the improvement in the liver function in the recovering patients were more significant than those in the unchanged patients ( P 〈 0.01 ). Conclusions The PE therapy can effectively purge the serum of HBV - DNA in patients with severe hepatitis B, reduce the iminunoreaetions, and improve the liver function. The survival rat of the patients should be increased.
出处 《华南国防医学杂志》 CAS 2005年第4期1-3,共3页 Military Medical Journal of South China
关键词 血浆置换 重型乙型肝炎 病毒载量 Plasma exchange Severe hepatitis B HBV- DNA
  • 相关文献

参考文献9

  • 1[1]Van de Kerkhove MP,Hoekstra R,Chamuleau RA,et al.Clinical application of bioartificial liver support systems.Ann Surg,2004,240(2):216~230 被引量:1
  • 2[2]Strain AJ,Neuberger JM.A bioartifical liver-state of the art.Science,2002,295(5557):1005~1009 被引量:1
  • 3[3]Liu JP,Kjaergard LL,Als-Nielsen B,et al.Artificial and bioartificial support systems for liver failure:a cochrane hepato-biliary group protocol.Liver,2002,22(5):433~438 被引量:1
  • 4[4]Jared W,Tarek H,Sangeeta N.Advances in bioartificial liver devices.Hepatology,2001,34(3):447~455 被引量:1
  • 5中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14010
  • 6中华医学会传染病与寄生虫病学分会肝衰竭与人工肝学组.人工肝支持系统技术和管理指南(摘要)[J].中华内科杂志,2003,42(1):65-67. 被引量:19
  • 7[7]Meindert NS,Leo SLA,Maarten-Paul K,et al.Assessment of the amc-bioatificial liver in the anhepatic pig.Transplantation,2002,73(2):204~209 被引量:1
  • 8[8]Anand AC.Bioartificial liver support for fulminant hepatic failure.Indian J Gastroenterol,2003,22(2):69~74 被引量:1
  • 9[9]Chanuleau RA.Bioartificial liver support anno 2001.Metal Brain Dis,2002,17(4):485~491 被引量:1

共引文献14017

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部